OPRX · NASDAQ
OptimizeRx (OPRX) Stock Price & Fundamentals
OptimizeRx (OPRX) closed at $480.06 on Oct 9, 2026, up 0.94% from the previous close of $475.61.
Share price, past year
1Y +29.88%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $480.06 |
| Sep 30, 2026 | $474.50 |
| Aug 31, 2026 | $442.15 |
| Jul 31, 2026 | $454.11 |
| Jun 30, 2026 | $454.36 |
| May 29, 2026 | $451.68 |
| Apr 30, 2026 | $426.55 |
| Mar 31, 2026 | $409.49 |
| Feb 27, 2026 | $383.37 |
| Jan 30, 2026 | $353.05 |
| Dec 31, 2025 | $366.49 |
| Nov 28, 2025 | $376.36 |
| Oct 31, 2025 | $365.64 |
Key statistics
- Market cap
- $9.04B
- P/E (TTM)
- 2,000.3
- EPS (TTM)
- $0.24
- Revenue (TTM)
- $98.65M
- Net income (TTM)
- $4.60M
- Shares outstanding
- 18.8M
- Dividend yield
- —
- 52-week range
- $350.59 – $482.94
OptimizeRx's market cap is $9.04B, based on a share price of $480.06 and 18.8M shares outstanding as of Jun 30, 2026.
Financials
OptimizeRx reported revenue of $109.43M for fiscal 2025, up 18.78% from fiscal 2024.
OptimizeRx earned net income of $5.13M in fiscal 2025, a net margin of 4.7%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $109.43M | +18.8% | $5.13M | 4.7% | $0.27 | $18.66M |
| FY2024ended Dec 31, 2024 | $92.13M | +28.8% | −$20.11M | −21.8% | −$1.10 | $4.78M |
| FY2023ended Dec 31, 2023 | $71.52M | +14.5% | −$17.57M | −24.6% | −$1.03 | −$7.33M |
| FY2022ended Dec 31, 2022 | $62.45M | +1.9% | −$11.44M | −18.3% | −$0.64 | $10.57M |
| FY2021ended Dec 31, 2021 | $61.29M | +41.5% | $378.08K | 0.6% | $0.02 | $625.72K |
| FY2020ended Dec 31, 2020 | $43.31M | +76.1% | −$2.21M | −5.1% | −$0.15 | −$6.38M |
| FY2019ended Dec 31, 2019 | $24.60M | +16.0% | −$3.14M | −12.8% | −$0.23 | −$1.75M |
| FY2018ended Dec 31, 2018 | $21.21M | +74.9% | $226.34K | 1.1% | $0.02 | $758.19K |
| FY2017ended Dec 31, 2017 | $12.13M | +56.5% | −$2.10M | −17.4% | −$0.21 | −$1.52M |
| FY2016ended Dec 31, 2016 | $7.75M | — | −$1.54M | −19.9% | −$0.05 | −$644.40K |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $20.50M | −$703.00K | −$0.04 |
| Q1 FY2026ended Mar 31, 2026 | $19.84M | −$495.00K | −$0.03 |
| Q4 FY2025ended Dec 31, 2025 | $32.24M | $5.02M | $0.27 |
| Q3 FY2025ended Sep 30, 2025 | $26.07M | $779.00K | $0.04 |
| Q2 FY2025ended Jun 30, 2025 | $29.20M | $1.53M | $0.08 |
| Q1 FY2025ended Mar 31, 2025 | $21.93M | −$2.20M | −$0.12 |
| Q4 FY2024ended Dec 31, 2024 | $32.32M | −$78.00K | $0.00 |
| Q3 FY2024ended Sep 30, 2024 | $21.31M | −$9.12M | −$0.50 |
Company profile
- Name
- OptimizeRx Corp
- Ticker
- OPRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Business Services, NEC
- Headquarters
- 260 Charles Street, Suite 302, Waltham, MA 02453
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001448431
Recent SEC filings
- Aug 13, 2026
- Aug 12, 2026
- Jun 12, 2026
- Jun 5, 2026
- May 13, 2026
- May 12, 2026
- Apr 9, 2026
- Mar 30, 2026
Frequently asked questions
What is OptimizeRx's stock price?
OptimizeRx (OPRX) closed at $480.06 on Oct 9, 2026, up 0.94% from the previous close of $475.61.
What is OptimizeRx's market cap?
OptimizeRx's market cap is $9.04B, based on a share price of $480.06 and 18.8M shares outstanding as of Jun 30, 2026.
How much revenue does OptimizeRx make?
OptimizeRx reported revenue of $109.43M for fiscal 2025, up 18.78% from fiscal 2024.
What is OPRX's P/E ratio?
OptimizeRx's price-to-earnings ratio is 2,000.3, based on trailing twelve-month diluted EPS of $0.24.
Does OptimizeRx pay a dividend?
OptimizeRx's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from OptimizeRx Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures